RARA and cancer: Selective RARα agonists have been shown to inhibit proliferation and induce apoptosis of mammary tumour oncogenesis in murine models (MMTV-neu and MMTVwnt1 transgenic mice) relevant to human cancer,13 and to inhibit LPS-induced B-lymphocyte proliferation.14